Creative Medical Technology News

Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit

Yahoo FinanceMar 16 10:14 ET

Creative Medical Technology Approves Executive Bonuses

TipRanksMar 14 16:59 ET

Creative Medical Technology | 10-K: FY2024 Annual Report

SECMar 14 16:30 ET · Announcements

Express News | Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds

ReutersMar 6 08:10 ET

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds

GlobeNewswireMar 6 08:10 ET

Creative Medical Technology Announces OvaStem Shows 85% Hormonal Improvement, 70% Success; Orphan Drug Designation Filed

BenzingaFeb 20 08:09 ET

Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem Program's Success and Growth Potential

GlobeNewswireFeb 20 08:00 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaFeb 14 07:05 ET

Express News | Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing Stemspine® Procedure Using Allostem™

ReutersFeb 14 07:00 ET

Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine Procedure Using AlloStem

GlobeNewswireFeb 14 07:00 ET

Creative Medical (CELZ) Shares Rally In After-Hour Trading

Stocks TelegraphFeb 14 03:15 ET

Creative Medical Technology's CELZ-201 Shows 80% Efficacy In Type 2 Diabetes Trial

RTTNewsFeb 11 12:01 ET

Creative Medical Technology Reports One-Year Results For AlloStem Type 2 Diabetes Program

BenzingaFeb 11 09:27 ET

Express News | Creative Medical Technology Holdings Inc - Celz-201 Achieves 80% Efficacy in Reducing Insulin Dependency

ReutersFeb 11 09:27 ET

Creative Medical Technology Reports Positive One-Year Results for AlloStem Type 2 Diabetes Program

GlobeNewswireFeb 11 09:25 ET

Express News | Creative Medical Technology Announces An Expanded Agreement With Greenstone Biosciences To Leverage Artificial Intelligence In Further Developing Its Human Induced Pluripotent Stem Cell Platform For Diabetes Treatment

BenzingaFeb 5 08:27 ET

Creative Medical Technology Holdings Expands Collaboration With Greenstone Biosciences to Accelerate IPSCelz Pipeline Development

GlobeNewswireFeb 5 08:25 ET

Express News | Creative Medical Technology Holdings Expands Collaboration With Greenstone Biosciences to Accelerate Ipscelz Pipeline Development

ReutersFeb 5 08:25 ET

Creative Medical Technology Holdings Shares Are Trading Higher After the Company Announced Initial Data From the First Cohort of Its Ongoing Phase 1/2 Clinical Trial of CELZ-201-DDT.

BenzingaJan 30 09:26 ET

Creative Medical Technology Holdings Announces Initial Safety, Tolerability, and Efficacy Data From First Cohort In Phase 1/2 Trial Of CELZ-201-DDT

BenzingaJan 30 09:25 ET